Impact of COVID-19 on Dendritic Cells
A recent study has shed light on the impact of COVID-19 on dendritic cells, a crucial component of our immune system responsible for immunity and activating T cells to combat diseases. The findings reveal that individuals who have survived COVID-19 experience a persistent decrease in dendritic cells, potentially putting them at a higher risk of developing secondary infections and requiring long-term symptom management.
Long-Term Effects of COVID-19
When it comes to the long-term effects of COVID-19, researchers have discovered that the virus can have a lasting impact on immunity. While the initial infection may resolve, some individuals may experience lingering symptoms such as fatigue, pain, and neurological issues. These persistent symptoms are believed to be caused by fragments of the virus that remain hidden in the organs.
Furthermore, these viral remnants can potentially trigger an exaggerated immune response and result in long-term inflammation. It is important to note that individuals experiencing these long-term effects are unlikely to be contagious or capable of transmitting the virus to others.